Epit.Ta
EPIT.TA operates in the healthcare services and equipment industry, primarily engaged in the medical equipment, supplies, and distribution sector.
Business. EPIT.TA operates in the healthcare services and equipment industry, primarily engaged in the medical equipment, supplies, and distribution sector.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
EPIT.TA operates in the healthcare services and equipment industry, primarily engaged in the medical equipment, supplies, and distribution sector.
The company's capital structure is characterized by a low debt-to-equity ratio of 0.21, indicating a conservative leverage position. It maintains a strong liquidity position with a current ratio of 6.23, supported by $13.65 million in cash and equivalents. However, the company's operating cash flow is negative at -$7.66 million, and free cash flow is also negative at -$9.41 million, suggesting ongoing cash flow challenges.
Profitability metrics are significantly negative, with a return on equity of -33.17% and a return on assets of -26.01%. These figures are well below the industry norms for medical equipment and supplies, indicating poor performance relative to its peers. The company reported a net loss of $8.61 million, with operating income also in the red at -$9.53 million.
The company's revenue concentration is not explicitly detailed in the available data, but the absence of segment-specific revenue breakdowns suggests a lack of diversification. This could pose a risk if the company's primary revenue streams face disruption. The geographic exposure is also not specified, which limits the understanding of regional dependencies.
The company's growth trajectory is uncertain, with no specific revenue growth projections provided. Historical revenue data shows a total of $213 million, but without prior period comparisons, it is difficult to assess growth trends. The negative operating and free cash flows indicate that the company is not generating sufficient internal funds to support expansion or debt servicing.
Risk factors include a low liquidity score, which suggests potential challenges in meeting short-term obligations. The company has a low dilution risk, with no immediate filing-based liquidity or dilution flags detected. However, the negative cash flows and profitability metrics indicate operational risks that could affect long-term stability.
Recent events and filings do not provide specific details on the company's operations or strategic initiatives. The absence of recent transcripts or significant filings suggests a lack of public disclosure on key business developments, which could affect investor confidence.
- The company has a strong liquidity position with a current ratio of 6.23, supported by $13.65 million in cash and equivalents.
- Profitability is significantly negative, with a return on equity of -33.17% and a return on assets of -26.01%.
- The company's capital structure is conservative, with a low debt-to-equity ratio of 0.21.
- There is no immediate filing-based liquidity or dilution risk, but the negative cash flows and profitability metrics indicate operational challenges.
- The company's growth trajectory is uncertain, with no specific revenue growth projections provided.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- EPIT.TA Market data — financials · 2026-05-27